• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺素和促甲状腺素对绝经后女性骨密度的影响:一项系统评价。

Effect of Thyroxine and Thyrotropin on Bone Mineral Density in Postmenopausal Women: A Systematic Review.

作者信息

Poudel Prakar, Chalasani Roopa, Goonathilake Mastiyage R, Waqar Sara, George Sheeba, Jean-Baptiste Wilford, Yusuf Ali Amina, Inyang Bithaiah, Koshy Feeba Sam, George Kitty, Mohammed Lubna

机构信息

Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

出版信息

Cureus. 2022 Jun 26;14(6):e26353. doi: 10.7759/cureus.26353. eCollection 2022 Jun.

DOI:10.7759/cureus.26353
PMID:35903569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9325683/
Abstract

The effect of thyroid hormones on bone mineral density in postmenopausal women has been reported but is not completely established. To better understand this relationship, this systematic review of the reported association, differences, and effects of thyroxine and/or thyrotropin levels on bone mineral density was conducted. An electronic literature search was conducted on MEDLINE, PMC, Google Scholar, Cochrane Library, and Science Direct from inception to April 2022; 20 studies were identified which include five quasi-experimental studies, three community cohort studies, and 12 hospital-based cross-sectional studies. Following an extensive evaluation, it was difficult to conclusively determine the association or effect of thyroxine or thyrotropin levels on bone mineral density in postmenopausal women. It is therefore suggested to conduct additional non-randomized or randomized control studies on this topic for the benefit of postmenopausal women. Particular attention should be given to the adjustment of age, body mass index, smoking status, alcohol consumption, and dietary calcium in future research on this topic for rigorous analysis.

摘要

甲状腺激素对绝经后女性骨密度的影响已有报道,但尚未完全明确。为了更好地理解这种关系,我们对已报道的甲状腺素和/或促甲状腺激素水平与骨密度之间的关联、差异及影响进行了系统综述。从创刊至2022年4月,我们在MEDLINE、PMC、谷歌学术、考克兰图书馆和科学直投数据库进行了电子文献检索;共识别出20项研究,其中包括5项准实验研究、3项社区队列研究和12项基于医院的横断面研究。经过广泛评估,很难最终确定甲状腺素或促甲状腺激素水平与绝经后女性骨密度之间的关联或影响。因此,建议针对这一主题开展更多非随机或随机对照研究,以造福绝经后女性。在今后关于该主题的研究中,应特别注意对年龄、体重指数、吸烟状况、饮酒量和膳食钙进行调整,以便进行严谨分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/9325683/a6deb0d9a0de/cureus-0014-00000026353-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/9325683/d28cd5ad9230/cureus-0014-00000026353-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/9325683/256d6936575f/cureus-0014-00000026353-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/9325683/152eb0eed24d/cureus-0014-00000026353-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/9325683/a6deb0d9a0de/cureus-0014-00000026353-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/9325683/d28cd5ad9230/cureus-0014-00000026353-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/9325683/256d6936575f/cureus-0014-00000026353-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/9325683/152eb0eed24d/cureus-0014-00000026353-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/9325683/a6deb0d9a0de/cureus-0014-00000026353-i04.jpg

相似文献

1
Effect of Thyroxine and Thyrotropin on Bone Mineral Density in Postmenopausal Women: A Systematic Review.甲状腺素和促甲状腺素对绝经后女性骨密度的影响:一项系统评价。
Cureus. 2022 Jun 26;14(6):e26353. doi: 10.7759/cureus.26353. eCollection 2022 Jun.
2
Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis.甲状腺癌术后甲状腺刺激素抑制对绝经后妇女骨密度的影响:系统评价和荟萃分析。
BMJ Open. 2021 May 13;11(5):e043007. doi: 10.1136/bmjopen-2020-043007.
3
Influence of thyroid hormones on bone density.甲状腺激素对骨密度的影响。
Med Glas (Zenica). 2020 Feb 1;17(1):35-40. doi: 10.17392/1056-20.
4
The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.促甲状腺激素水平在维持绝经后女性骨密度方面似乎较为有利。
Endocr Regul. 2010 Jan;44(1):9-15. doi: 10.4149/endo_2010_01_9.
5
A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.小剂量抑制性左甲状腺素对患有非毒性甲状腺肿的绝经前和绝经后女性的骨转换及骨密度无影响。
Horm Metab Res. 1995 Nov;27(11):503-7. doi: 10.1055/s-2007-980012.
6
Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis.甲状腺癌和慢性淋巴细胞性甲状腺炎绝经后女性长期接受左甲状腺素治疗后的脊柱骨量
Calcif Tissue Int. 1994 Jan;54(1):16-9. doi: 10.1007/BF00316283.
7
High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.甲状腺功能正常的绝经后女性中,游离甲状腺素水平略高于正常范围与低骨小梁评分相关。
Osteoporos Int. 2016 Feb;27(2):457-62. doi: 10.1007/s00198-015-3270-3. Epub 2015 Aug 8.
8
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
9
Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism.甲状腺素治疗对绝经后甲状腺功能减退女性骨代谢的影响。
Acta Obstet Gynecol Scand. 1996 Oct;75(9):843-8. doi: 10.3109/00016349609054714.
10
Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy.接受长期左旋甲状腺素治疗的绝经前和绝经后女性的骨骼完整性。
Am J Med. 1991 Jul;91(1):5-14. doi: 10.1016/0002-9343(91)90066-7.

本文引用的文献

1
Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.促甲状腺激素与甲状腺功能正常的绝经后女性的小梁骨评分及5年骨折发生风险相关:OsteoLaus队列研究
Osteoporos Int. 2022 Jan;33(1):195-204. doi: 10.1007/s00198-021-06081-4. Epub 2021 Aug 19.
2
Low TSH Levels Within Euthyroid Range Could Play a Negative Role on Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes.甲状腺功能正常范围内的低促甲状腺激素水平可能对绝经后2型糖尿病女性的骨密度产生负面影响。
Diabetes Metab Syndr Obes. 2021 May 24;14:2349-2355. doi: 10.2147/DMSO.S307633. eCollection 2021.
3
Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score.
分化型甲状腺癌绝经后女性促甲状腺素抑制治疗后的骨健康测量:骨密度与小梁骨评分对比
J Clin Med. 2021 May 3;10(9):1964. doi: 10.3390/jcm10091964.
4
Influence of thyroid hormones on bone density.甲状腺激素对骨密度的影响。
Med Glas (Zenica). 2020 Feb 1;17(1):35-40. doi: 10.17392/1056-20.
5
Evaluation of Thyroid Hormone Status and Bone Density Ratio in Euthyroid Postmenopausal Women in Early and Late Stage of Bone Loss.甲状腺功能正常的绝经后女性骨量丢失早晚期甲状腺激素状态及骨密度比值的评估
Mater Sociomed. 2019 Jun;31(2):115-118. doi: 10.5455/msm.2019.31.115-118.
6
Effects of thyrotropin suppression on lumbar bone mineral density in postmenopausal women with differentiated thyroid carcinoma.促甲状腺素抑制对绝经后分化型甲状腺癌女性腰椎骨密度的影响。
Onco Targets Ther. 2018 Oct 9;11:6687-6692. doi: 10.2147/OTT.S171282. eCollection 2018.
7
The effect of suppressive thyroxine therapy in nodular goiter in postmenopausal women and 2 year's bone mineral density change.抑制性甲状腺素治疗对绝经后妇女结节性甲状腺肿的影响及两年骨密度变化
Endocr J. 2018 Nov 29;65(11):1101-1109. doi: 10.1507/endocrj.EJ18-0125. Epub 2018 Aug 30.
8
Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.长期 TSH 抑制治疗后绝经后分化型甲状腺癌患者的低小梁骨评分。
Endocrine. 2018 Oct;62(1):166-173. doi: 10.1007/s12020-018-1671-8. Epub 2018 Jul 16.
9
The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated Thyroid Carcinoma.促甲状腺激素抑制对分化型甲状腺癌患者椎骨小梁骨评分的影响
J Clin Endocrinol Metab. 2017 Jan 1;102(1):78-85. doi: 10.1210/jc.2016-2740.
10
Low Thyroid Stimulating Hormone Levels Are Associated with Low Bone Mineral Density in Femoral Neck in Elderly Women.老年女性中,促甲状腺激素水平低与股骨颈骨密度低有关。
Arch Med Res. 2016 May;47(4):310-4. doi: 10.1016/j.arcmed.2016.07.009.